查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595512

产后忧郁症治疗市场：依治疗类型、分布 - 2025-2030 年全球预测

Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年产后忧郁症治疗市值为9.4854亿美元，预计到2024年将达到10.2686亿美元，复合年增长率为8.74%，预计到2030年将达到17.0558亿美元。

产后忧郁症(PPD) 治疗包括各种治疗性介入，以缓解产后忧郁症母亲的症状。这部分强调药理学方法（例如抗忧郁症和荷尔蒙疗法）和非药理学策略（例如心理治疗和生活方式改变）。人们越来越认识到产后忧郁症的盛行率，全世界大约 10-20% 的新生儿都受到产后忧郁症的影响，而且它对孕产妇和新生儿的健康也产生了重大影响。这些治疗的应用根据症状的严重、获得护理的机会和意识而有很大差异，这突显出需要量身定制的方法。最终用途范围主要包括医院、妇产诊所、精神卫生中心和居家照护机构。市场成长的关键影响因素包括提高意识宣传活动、远端医疗的进步以及医疗基础设施支出的增加。个人化医疗和开发满足特定患者需求的数位健康解决方案存在机会。促进早期诊断和治疗依从性的数位平台尤其有前景。然而，围绕心理健康的社会耻辱、获得医疗保健的机会差异以及心理健康治疗保险范围的限制对市场成长构成了挑战。临床理解的限制和治疗的潜在副作用进一步限制了采用率。非侵入性脑刺激技术、基于扩增实境的治疗性介入以及人工智慧主导的早期诊断预测分析等领域的创新可能会蓬勃发展。随着越来越多的製药公司进入市场，利用未满足的需求和生物技术的进步来提供更有效的治疗方法，市场正在不断发展。研究应着重于纵向研究，以更好地了解 PPD 的发病机制，并开发副作用较少、疗效较高的新疗法。该市场的特点是技术创新迅速，并且有强烈的动力来解决这一影响大但讨论不足的心理健康领域，为增长和影响提供了巨大的机会。

主要市场统计
基准年[2023] 94854万美元
预测年份 [2024] 1,026,860,000 美元
预测年份 [2030] 1,705.58 百万美元
复合年增长率（%） 8.74%

市场动态：揭示快速发展的产后忧郁症治疗市场的关键市场洞察

供需的动态交互作用正在改变产后忧郁症治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球与妊娠相关的情绪障碍盛行率上升
    • 抗忧郁症和谈话疗法的需求不断增长
    • 增加对 PPD 治疗的监管核准
  • 市场限制因素
    • 医护人员短缺
  • 市场机会
    • 提高远端医疗和远端医疗的可用性
    • 新兴市场 PPD 治疗研究活动活性化
  • 市场问题
    • 产品召回问题

波特五力：驾驭产后忧郁症治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解产后忧郁症治疗市场的外在影响

外部宏观环境因素在塑造产后忧郁症治疗市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解产后忧郁症治疗市场的竞争格局

产后忧郁症治疗市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：产后忧郁症治疗市场供应商的绩效评估

FPNV 定位矩阵是评估产后忧郁症治疗市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：制定产后忧郁症治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对产后忧郁症治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、核准核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球与妊娠相关的情绪障碍盛行率增加
      • 抗忧郁症和谈话疗法的需求增加
      • 增加对 PPD 治疗的监管核准
    • 抑制因素
      • 医疗专业人员短缺
    • 机会
      • 扩大远端医疗和远距医疗的可用性
      • 新兴市场产后忧郁症(PPD) 治疗的研究活动增加
    • 任务
      • 产品召回问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章产后忧郁症治疗市场：依治疗类型

  • 介绍
  • 抗忧郁症
    • 安非他酮
    • 地昔帕明
    • escitalopram
    • 帕罗西汀
    • 舍曲林
    • 反苯环丙明
    • 曲米帕明
  • 心理治疗
    • 认知行为疗法
    • 人际心理治疗
    • 心理动力心理治疗
    • 以解决方案为导向的短期心理治疗

第七章产后忧郁症治疗市场：依分布

  • 介绍
  • 药局
  • 电子商务
  • 医院药房
  • 零售药房

第八章北美和南美产后忧郁症治疗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区产后忧郁症治疗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲产后忧郁症治疗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Accord Healthcare Ltd.
  • Alvogen Group Inc
  • Anikem Laboratories
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Cipla Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Intas Pharmaceuticals Ltd.
  • Lupin Ltd.
  • Mylan NV
  • Novartis AG
  • Pfizer, Inc.
  • Sage Therapeutics, Inc.
  • Sebela Pharmaceuticals, Inc.
  • Shionogi & Company, Limited
  • Solvay SA
  • Sumika Polymer Compounds（EU）Ltd
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceuticals Industries Ltd.
Product Code: MRR-0372A4B9143E

The Postpartum Depression Treatment Market was valued at USD 948.54 million in 2023, expected to reach USD 1,026.86 million in 2024, and is projected to grow at a CAGR of 8.74%, to USD 1,705.58 million by 2030.

Postpartum depression (PPD) treatment encompasses a range of therapeutic interventions designed to alleviate symptoms in mothers experiencing depression following childbirth. This sector emphasizes both pharmacological approaches, such as antidepressants and hormone therapy, and non-pharmacological strategies, including psychotherapy and lifestyle modifications. The necessity for such treatments is underscored by the increasing recognition of PPD's prevalence, affecting approximately 10-20% of new mothers globally, and its profound impact on both maternal and neonatal health. The application of these treatments varies significantly based on the severity of the condition, access to healthcare, and awareness levels, highlighting an immense need for tailored approaches. End-use scope primarily involves hospitals, maternity clinics, mental health centers, and home care settings. Key influencing factors for market growth include the rise in awareness campaigns, advancements in telemedicine, and increased healthcare infrastructure spending. Opportunities lie in developing personalized medicine and digital health solutions that cater to specific patient needs. Digital platforms that facilitate early diagnosis and treatment adherence are particularly promising. However, market growth is challenged by societal stigma surrounding mental health, disparities in healthcare access, and limited insurance coverage for mental health treatments. Limitations in clinical understanding and the potential side effects of treatments further constrain adoption rates. Innovation could thrive in areas such as non-invasive brain stimulation techniques, augmented reality-based therapeutic interventions, and AI-driven predictive analytics for early diagnosis. The market is evolving with increased participation from pharmaceutical companies keen to capitalize on unmet needs and advancements in biotechnology promising more effective treatment modalities. Research should focus on longitudinal studies to better understand the etiology of PPD and the development of novel therapeutics that offer better efficacy with fewer side effects. The market's nature is characterized by rapid innovation and a strong incentive to address a highly impacting yet often under-discussed mental health segment, presenting considerable opportunities for growth and impact.

KEY MARKET STATISTICS
Base Year [2023] USD 948.54 million
Estimated Year [2024] USD 1,026.86 million
Forecast Year [2030] USD 1,705.58 million
CAGR (%) 8.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Postpartum Depression Treatment Market

The Postpartum Depression Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalences of mood disorder associated with pregnancy across the globe
    • Growing demand for antidepressant medication and talk therapies
    • Increasing approvals from regulatory bodies for PPD treatment
  • Market Restraints
    • Limited availability of medical professionals
  • Market Opportunities
    • Growing availability of telehealth and telemedicine
    • Rising research activities for treatment of Postpartum Depression Treatment (PPD) in emerging markets
  • Market Challenges
    • Issues related to product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Postpartum Depression Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Postpartum Depression Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Postpartum Depression Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Postpartum Depression Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Postpartum Depression Treatment Market

A detailed market share analysis in the Postpartum Depression Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Postpartum Depression Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Postpartum Depression Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Postpartum Depression Treatment Market

A strategic analysis of the Postpartum Depression Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Postpartum Depression Treatment Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare Ltd., Alvogen Group Inc, Anikem Laboratories, AstraZeneca PLC, Bausch Health Companies Inc., Cipla Limited, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck A/S, Intas Pharmaceuticals Ltd., Lupin Ltd., Mylan N.V., Novartis AG, Pfizer, Inc., Sage Therapeutics, Inc., Sebela Pharmaceuticals, Inc., Shionogi & Company, Limited, Solvay S.A., Sumika Polymer Compounds (EU) Ltd, Sun Pharmaceutical Industries Limited, and Teva Pharmaceuticals Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Postpartum Depression Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Antidepressant Drugs and Psychotherapy. The Antidepressant Drugs is further studied across Bupropion, Desipramine, Escitalopram, Paroxetine, Sertraline, Tranylcypromine, and Trimipramine. The Psychotherapy is further studied across Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Psychodynamic Psychotherapy, and Solution-Focused Brief Psychotherapy.
  • Based on Distribution, market is studied across Drug Stores, E-Commerce, Hospital Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalences of mood disorder associated with pregnancy across the globe
      • 5.1.1.2. Growing demand for antidepressant medication and talk therapies
      • 5.1.1.3. Increasing approvals from regulatory bodies for PPD treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of medical professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing availability of telehealth and telemedicine
      • 5.1.3.2. Rising research activities for treatment of Postpartum Depression Treatment (PPD) in emerging markets
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Postpartum Depression Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Antidepressant Drugs
    • 6.2.1. Bupropion
    • 6.2.2. Desipramine
    • 6.2.3. Escitalopram
    • 6.2.4. Paroxetine
    • 6.2.5. Sertraline
    • 6.2.6. Tranylcypromine
    • 6.2.7. Trimipramine
  • 6.3. Psychotherapy
    • 6.3.1. Cognitive Behavioral Therapy
    • 6.3.2. Interpersonal Psychotherapy
    • 6.3.3. Psychodynamic Psychotherapy
    • 6.3.4. Solution-Focused Brief Psychotherapy

7. Postpartum Depression Treatment Market, by Distribution

  • 7.1. Introduction
  • 7.2. Drug Stores
  • 7.3. E-Commerce
  • 7.4. Hospital Pharmacies
  • 7.5. Retail Pharmacies

8. Americas Postpartum Depression Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Postpartum Depression Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Postpartum Depression Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accord Healthcare Ltd.
  • 2. Alvogen Group Inc
  • 3. Anikem Laboratories
  • 4. AstraZeneca PLC
  • 5. Bausch Health Companies Inc.
  • 6. Cipla Limited
  • 7. Eli Lilly and Company
  • 8. GlaxoSmithKline PLC
  • 9. H. Lundbeck A/S
  • 10. Intas Pharmaceuticals Ltd.
  • 11. Lupin Ltd.
  • 12. Mylan N.V.
  • 13. Novartis AG
  • 14. Pfizer, Inc.
  • 15. Sage Therapeutics, Inc.
  • 16. Sebela Pharmaceuticals, Inc.
  • 17. Shionogi & Company, Limited
  • 18. Solvay S.A.
  • 19. Sumika Polymer Compounds (EU) Ltd
  • 20. Sun Pharmaceutical Industries Limited
  • 21. Teva Pharmaceuticals Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. POSTPARTUM DEPRESSION TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. POSTPARTUM DEPRESSION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. POSTPARTUM DEPRESSION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POSTPARTUM DEPRESSION TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POSTPARTUM DEPRESSION TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY BUPROPION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DESIPRAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ESCITALOPRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PAROXETINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SERTRALINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRANYLCYPROMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TRIMIPRAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY INTERPERSONAL PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHODYNAMIC PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY SOLUTION-FOCUSED BRIEF PSYCHOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY PSYCHOTHERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 196. POSTPARTUM DEPRESSION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. POSTPARTUM DEPRESSION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023